Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
farletuzumab | folate receptor alpha | biotech | Successful target | TTD , drugbank , DGIDB | Malignant neoplasm of ovary[MeSHID:D010051] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
25.46 | investigational,phase 3 | antibody,inhibitor |
farletuzumab | folate receptor alpha | biotech | Successful target | TTD , drugbank , DGIDB | Malignant neoplasm of ovary[MeSHID:D010051] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
25.46 | investigational,phase 3 | antibody |
click here to return to the previous page |